Introduction
This patent delves into the detailed examination of the Akkermansia muciniphila Akk007, a probiotic with significant immunomodulatory properties. The strain has shown promise in enhancing immune function and is proposed for various applications in health supplements and functional foods.
Characteristics:
Akkermansia muciniphila Akk007 is identified for its ability to...
Abstract:
The present study introduces a composite probiotic blend comprising Bifidobacterium animalis subsp. lactis BLa36 and Bifidobacterium breve BBr60. This blend demonstrates synergistic effects in stabilizing mood by balancing neurotransmitters, reducing stress responses, and improving behavioral symptoms. The potential application of this probiotic blend in the...
In a groundbreaking study published in Frontiers in Immunology, researchers from Tokyo University of Science have uncovered a potential mechanism by which gut bacteria can positively influence inflammatory bowel disease (IBD). This discovery has significant implications for the probiotic industry, including companies like Wecare Probiotics Co., Ltd., which is dedicated to the research and...
Abstract
This study presents the discovery and application of Lacticaseibacillus rhamnosus LRa66, a novel probiotic strain exhibiting significant capabilities of blood glucose and lipid reduction. Isolated from human breast milk, LRa66 demonstrates superior tolerance to gastric acid, intestinal fluid, and bile salts. It has been shown to effectively ameliorate metabolic syndrome...
Akkermansia muciniphila (AKK), often referred to as the “longevity probiotic,” has garnered increasing attention for its promising role in promoting healthy aging. Recent studies have highlighted how this unique gut microbe influences multiple markers of aging, contributing to better metabolic health, immune regulation, and overall vitality. As we dive into the potential of...
Wecare Probiotics Co., Ltd., a leading national high-tech enterprise in the field of probiotics, is pleased to share new insights from a recent meta-analysis conducted by Chinese researchers, which highlights the effectiveness of probiotic and synbiotic supplementation in improving bowel function in adults suffering from constipation. The study, published in Pharmacology and Therapeutics,...
Patent Application Number:
202410239290.9
Applicants:
Wecare Probiotics Co., Ltd.
Inventors:
Fang Shuguang, Dong Yao, Qi Yongmei, Qian Limin
Filed Date:
March 4, 2024
Publication Date:
April 9, 2024
Abstract:
This invention relates to a probiotic preparation designed to regulate brain-derived neurotrophic factor (BDNF) and sex hormones. The preparation...
The intricate relationship between the gut microbiome and drug efficacy is gaining attention in the pharmaceutical industry, as highlighted during NutraIngredients' 2024 Probiota event. Nathan Price, Chief Scientific Officer at Thorne, emphasized the significant influence of gut bacteria on medication metabolism, suggesting that the microbiome is a critical factor in personalized medicine....
Introduction
Chronic periodontitis, an inflammatory disease, involves the excessive colonization of pathogens like Porphyromonas gingivalis and Fusobacterium nucleatum, leading to tissue damage and potential tooth loss. Traditional treatment using antibiotics disrupts the oral ecosystem and promotes drug resistance. This study evaluates the efficacy of probiotics, specifically...
Background:
As individuals age, the reproductive tract undergoes natural degenerative changes, leading to an altered microenvironment and imbalances in microbial communities. These changes can decrease reproductive functionality and increase the risk of associated diseases. Conventional treatments often rely on hormone replacement therapy, which carries risks of side effects and does not...
Portuguese 
English
Arabic
French
Spanish
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek